DRI Sezed 107 Litres Of Liquid Mephedrone From Apex Medichem

Ahmedabad: After the mega drug bust carried out jointly by the Directorate of Revenue Intelligence (DRI) Pune and Ahmedabad Crime Branch on October 21 at a factory in Maharashtra’s Aurangabad, another factory came under crackdown in the city on Saturday.

Banned drugs worth about Rs 160 crore have been recovered in the latest case, officials said.

The owner of the factory and the warehouse manager have been arrested under the provisions of the Narcotic Drugs and Psychotropic Substances (NDPS) Act.

“The search of the factory premises of a company named Apex Medichem Pvt. Ltd. resulted in the recovery of about 107 litres of liquid Mephedrone. The Illicit market value of these narcotics drugs and psychotropic substances has been reported to be approximately Rs160 crore, ” stated an official release.

 

Related Posts

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

New Delhi: Alembic Pharmaceuticals has received final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Levothyroxine Sodium Tablets USP in…

STF busts fake meds racket spread across 6 states

Dehradun: Uttarakhand special task force (STF) on Friday busted an online fake medicine racket operating through a Facebook page that allegedly sold counterfeit drugs, including cancer medicines, at discounts of…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

STF busts fake meds racket spread across 6 states

STF busts fake meds racket spread across 6 states

All the Way from Teeth to Tee: Hole in One

All the Way from Teeth to Tee: Hole in One

Zydus Lifesciences Q4FY26 net profit rises 9%

Zydus Lifesciences Q4FY26 net profit rises 9%

Chemists strike on May 20: Reasons behind today’s all-India strike

Chemists strike on May 20: Reasons behind today’s all-India strike

AbbVie loses patent plea for Hep C drug

AbbVie loses patent plea for Hep C drug